Bridgefront Capital, LLC Zoetis Inc. Transaction History

Bridgefront Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $699,458 - $844,146	4,222 New	4,222 $714,000
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $754,841 - $906,397	5,756 New	5,756 $843,000
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $181,861 - $233,304	-1,166 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $211,500 - $272,878	1,166 New	1,166 $220,000
Q2 2021 Aug 12, 2021	SELL	$155.9 - $187.99 $2.12 Million - $2.56 Million	-13,604 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $1.75 Million - $2.06 Million	12,165 Added 845.38%	13,604 $2.14 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $226,023 - $250,889	1,439 New	1,439 $238,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.